These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 24823461

  • 1. IGF-1 and growth response to adult height in a randomized GH treatment trial in short non-GH-deficient children.
    Kriström B, Lundberg E, Jonsson B, Albertsson-Wikland K, study group.
    J Clin Endocrinol Metab; 2014 Aug; 99(8):2917-24. PubMed ID: 24823461
    [Abstract] [Full Text] [Related]

  • 2. Dose-dependent effect of growth hormone on final height in children with short stature without growth hormone deficiency.
    Albertsson-Wikland K, Aronson AS, Gustafsson J, Hagenäs L, Ivarsson SA, Jonsson B, Kriström B, Marcus C, Nilsson KO, Ritzén EM, Tuvemo T, Westphal O, Aman J.
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4342-50. PubMed ID: 18728172
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial.
    Van Pareren Y, Mulder P, Houdijk M, Jansen M, Reeser M, Hokken-Koelega A.
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3584-90. PubMed ID: 12915640
    [Abstract] [Full Text] [Related]

  • 5. Growth response to growth hormone (GH) treatment relates to serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in short children with various GH secretion capacities. Swedish Study Group for Growth Hormone Treatment.
    Kriström B, Jansson C, Rosberg S, Albertsson-Wikland K.
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2889-98. PubMed ID: 9284715
    [Abstract] [Full Text] [Related]

  • 6. Free/dissociable insulin-like growth factor (IGF)-I, not total IGF-I, correlates with growth response during growth hormone treatment in children born small for gestational age.
    Bannink EM, van Doorn J, Mulder PG, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2992-3000. PubMed ID: 17504895
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Growth hormone (GH) dose-dependent IGF-I response relates to pubertal height gain.
    Lundberg E, Kriström B, Jonsson B, Albertsson-Wikland K, study group.
    BMC Endocr Disord; 2015 Dec 18; 15():84. PubMed ID: 26682747
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The insulin-like growth factor-I response to growth hormone is increased in prepubertal children with obesity and tall stature.
    Bouhours-Nouet N, Gatelais F, Boux de Casson F, Rouleau S, Coutant R.
    J Clin Endocrinol Metab; 2007 Feb 18; 92(2):629-35. PubMed ID: 17090643
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
    Binder G, Baur F, Schweizer R, Ranke MB.
    J Clin Endocrinol Metab; 2006 Feb 18; 91(2):659-64. PubMed ID: 16291706
    [Abstract] [Full Text] [Related]

  • 13. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB, Traunecker R, Martin DD, Schweizer R, Schwarze CP, Wollmann HA, Binder G.
    Horm Res; 2005 Feb 18; 64(2):68-76. PubMed ID: 16113581
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study.
    Cohen P, Rogol AD, Howard CP, Bright GM, Kappelgaard AM, Rosenfeld RG, American Norditropin Study Group.
    J Clin Endocrinol Metab; 2007 Jul 18; 92(7):2480-6. PubMed ID: 17356043
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome.
    de Lind van Wijngaarden RF, Siemensma EP, Festen DA, Otten BJ, van Mil EG, Rotteveel J, Odink RJ, Bindels-de Heus GC, van Leeuwen M, Haring DA, Bocca G, Houdijk EC, Hoorweg-Nijman JJ, Vreuls RC, Jira PE, van Trotsenburg AS, Bakker B, Schroor EJ, Pilon JW, Wit JM, Drop SL, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2009 Nov 18; 94(11):4205-15. PubMed ID: 19837938
    [Abstract] [Full Text] [Related]

  • 18. Growth hormone (GH) dosing during catch-up growth guided by individual responsiveness decreases growth response variability in prepubertal children with GH deficiency or idiopathic short stature.
    Kriström B, Aronson AS, Dahlgren J, Gustafsson J, Halldin M, Ivarsson SA, Nilsson NO, Svensson J, Tuvemo T, Albertsson-Wikland K.
    J Clin Endocrinol Metab; 2009 Feb 18; 94(2):483-90. PubMed ID: 19001519
    [Abstract] [Full Text] [Related]

  • 19. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N, Attie KM, Reiter EO, Saenger P, Baptista J.
    J Clin Endocrinol Metab; 2000 Oct 18; 85(10):3653-60. PubMed ID: 11061518
    [Abstract] [Full Text] [Related]

  • 20. The Effect of Recombinant Growth Hormone Treatment in Children with Idiopathic Short Stature and Low Insulin-Like Growth Factor-1 Levels.
    Şıklar Z, Kocaay P, Çamtosun E, İsakoca M, Hacıhamdioğlu B, Savaş Erdeve Ş, Berberoğlu M.
    J Clin Res Pediatr Endocrinol; 2015 Dec 18; 7(4):301-6. PubMed ID: 26777041
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.